SWOG S1929

Primary Category:

Treatment Protocols

Disease Category:

Lung - Small Cell Extensive Stage

Status:

Open

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)

S1929, Step 1 Screening Registration is permanently closed to accrual, effective August 15, 2022, at 3:45am PT.  Step 2 Randomization remains open until further notice.

NCT#04334941